Status:
UNKNOWN
Pharmacokinetic Study of Marine Active in Health Men
Lead Sponsor:
China Medical University Hospital
Conditions:
Hyperuricemia, Anserine, Pharmacokinetic
Eligibility:
MALE
20-35 years
Phase:
PHASE1
Brief Summary
Hyperuricemia is often associated with metabolic syndrome, which is a known precursor of atherosclerosis. The Yaizu Suisankagaku Industry Company have developed industrial production, named Marine Act...
Detailed Description
Hyperuricemia is a common metabolic disorder. It can result from a decreased renal uric acid excretion, increased urate production, or both. The classical association with clinical gout is well-known....
Eligibility Criteria
Inclusion
- Male volunteers, age between 20 to 35 years
Exclusion
- Chronic medical history
- Significant liver or renal dysfunction,
- Have been administrated by any drug within 2 weeks before the initiation of study.
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00207974
Last Update
November 17 2005
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
China Medical University Hospital
Taichung, Taiwan